Huang Pu

Managing Partner

14 past transactions

Alebund Pharmaceuticals

Series C in 2025
Alebund Pharmaceuticals is a biopharmaceutical company specializing in the discovery and development of innovative therapies for renal diseases and associated chronic conditions. The company focuses on researching and commercializing treatments for a variety of kidney-related ailments, including chronic kidney disease, dialysis complications, nephropathy, diabetic kidney disease, and autosomal dominant polycystic kidney disease. With a diversified pipeline of drug candidates, Alebund Pharmaceuticals aims to deliver comprehensive, high-quality solutions to patients suffering from renal diseases, addressing both immediate and long-term healthcare needs in this critical area.

IMPACT Therapeutics

Series D in 2024
IMPACT Therapeutics, Inc. is a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapeutics for cancer and other life-threatening diseases. Founded in 2009 and based in Shanghai, China, the company focuses on creating targeted anti-cancer treatments utilizing synthetic lethality. IMPACT Therapeutics is actively engaged in several research and development projects, including a PARP inhibitor, a Wee1 inhibitor, and various novel agents targeting DNA damage response mechanisms and the Hedgehog signaling pathway. Through its commitment to advancing treatment options, IMPACT Therapeutics aims to provide patients with effective and targeted anti-cancer therapies.

A new energy

Venture Round in 2023
A new energy provides photovoltaic new energy system application solutions is committed to manufacturing and selling N-type high-efficiency photovoltaic cells, components, and system applications, as well as investing in and integrating power station construction and operation. They offer ecological photovoltaic, urban photovoltaic, and offshore PV solutions.

TopOlefin Technology

Series B in 2023
TopOlefin Technology specializes in the research, development, and production of advanced polymer materials, with a focus on high-end optical resins. The company is dedicated to creating products characterized by high transparency, high refractive index, and strong gas barrier properties. These innovative materials find applications across various industries, including optical lenses, medical packaging, and consumer packaging. By prioritizing green and intelligent design, TopOlefin Technology aims to deliver high-quality resin solutions that meet the diverse needs of its clients.

Zhitong Precision

Venture Round in 2023
Zhitong Precision is a producer of industrial robots. They provide products that include machine tools, wind power, AGV cars, ships, construction machinery, and high-speed rail. They offer components and industrial automation production line solutions.

Trinomab

Venture Round in 2022
Trinomab Biotech is a clinical-stage biopharmaceutical company specializing in the discovery and development of novel fully native human monoclonal antibody (mAb) drugs. The company's core technology is known as HitmAb, a proprietary technology platform with differentiated advantages and high efficiency for the discovery of fully native human mAbs against infectious diseases, autoimmune disorders, malignant tumors, and other human diseases.

Epigenic Therapeutics

Seed Round in 2022
Epigenic Therapeutics is a biotechnology company focused on developing gene editing therapies that leverage gene-silencing technology to address a range of diseases. The firm specializes in epigenome editing, aiming to regulate various conditions, including those related to ophthalmology, neurodegeneration, metabolism, and rare diseases. By creating innovative treatments, Epigenic Therapeutics seeks to offer effective solutions for patients suffering from chronic and severe health issues.

LINX Robot

Series B in 2022
Linx Robot is a company that specializes in developing industrial robots for various sectors, including warehousing, manufacturing, logistics, food, and agriculture. Founded in 2017 and based in Yuhang, China, the company offers a range of products such as sorting systems, unpacking systems, package systems, vision cameras, and robot controllers. Linx Robot focuses on industrial upgrading and provides unmanned solutions that leverage advanced computer vision technology and robotic intelligent planning. Its innovative automation solutions are designed to enhance efficiency and reliability in industrial operations.

Blue Elephant Zhilian

Series A in 2022
Blue Elephant Zhilian is a developer of a financial privacy computing platform. The company's platform are licensed under the Ministry of Industry and Information Technology and Ministry of Public Security of China.

Atom Bioscience

Series C in 2022
Atom Bioscience is a clinical-stage biotechnology company dedicated to developing innovative therapies for inflammatory and metabolic diseases. The company focuses on conditions such as chronic gout and non-alcoholic steatohepatitis (NASH), as well as metabolic disorders and certain cancers. By concentrating on the intersections of metabolism and inflammation, Atom Bioscience aims to provide patients with more effective treatment options for these challenging health issues.

Youibot

Series B in 2021
Youibot Robotics Co., Ltd. is a Chinese company focused on the research, development, and manufacturing of autonomous mobile robots. The firm has independently developed a cutting-edge robot platform that utilizes advanced laser radar and visual real-time SLAM technology for navigation and mapping. Youibot's innovative systems are designed for both indoor and outdoor applications, offering competitive solutions for various industries. Their product line includes autonomous robots equipped with a standalone control system and a cluster collaboration platform, enabling efficient and automated operations for clients.

Beijing Star Theatres

Seed Round in 2021
Beijing Star Theatres operates a private theater culture industrial park focused on enhancing the performing arts industry in Southwest China. The facility encompasses a variety of offerings, including drama production, creative theater, and cultural activities that advocate for literary and artistic life. It features five distinct small theaters, contemporary art galleries, and themed spaces such as literary book bars and restaurants. The park aims to foster artistic creation and performance while also engaging in copyright transactions and the development of artistic derivatives. Additionally, it serves as a platform for artists to showcase their talents and provides a cultural experience for visitors through diverse shows and culinary options.

Lanxin

Venture Round in 2020
Lanxin Mobile (Beijing) Technology Co., Ltd. is a mobile Internet company based in Beijing, China, that specializes in providing a work platform tailored for large organizations, including government agencies, state-owned enterprises, and the military. The platform is designed to enhance hierarchical decentralization and visibility management, facilitating work communication, multi-terminal viewing, and document security. It includes features such as multi-level directory permission control, video conferencing, and support for large conference calls, enabling users to locate individuals based on their attributes and organizational levels. Additionally, Lanxin offers cloud-based, AI-driven collaborative IT solutions that promote secure and efficient working environments, fostering digital transformation and organizational innovation.

Qi An Xin

Private Equity Round in 2019
Qi An Xin Group is a prominent cybersecurity company based in Beijing, China, specializing in the protection of critical internet assets across various sectors, including government, finance, energy, and telecommunications. Founded in 2015, the company has experienced rapid growth, achieving over 90% consecutive compound annual growth rate since its inception. Qi An Xin offers a range of security solutions, including big data security, endpoint security, content security, and advanced detection and monitoring systems for cyber threats such as DDoS attacks and phishing. With a workforce of over 6,000 professionals, the company has successfully implemented its technologies in approximately 90% of government departments, state-owned enterprises, and major banks in China. Since 2019, Qi An Xin has also begun expanding its international presence, establishing operations in countries such as Indonesia, Singapore, Canada, Hong Kong, and Macao.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.